Navigation Links
Combination of drugs produces dramatic tumor responses in advanced melanoma patients
Date:6/2/2013

CHICAGO, JUNE 2, 2013 The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published online on Sunday, June 2, in The New England Journal of Medicine and presented by Memorial Sloan-Kettering Cancer Center researchers at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).

Several patients experienced tumor shrinkage of more than 80 percent within 12 weeks of receiving the drugs, and the shrinkage was long lasting. Further, 40 percent of patients who received varying concurrent dosages had an objective response meaning at least a 50 percent reduction in tumor size. Side effects from the drug combination were manageable and often reversible.

"We are very excited about the response rates these patients have experienced. This kind of deep and rapid tumor regression has never been seen in melanoma using immunotherapy, and suggests that these two drugs could be better used in combination than alone," said Jedd D. Wolchok, MD, PhD. Dr. Wolchok, a medical oncologist at the Ludwig Center for Cancer Immunotherapy at Memorial Sloan-Kettering, is lead author on The New England Journal of Medicine paper and also presented the findings at ASCO.

Dr. Wolchok and his team combined ipilimumab and nivolumab because promising results in preclinical testing suggested the drugs impact the immune system in a complementary way. By blocking the inhibitory marker CTLA-4, ipilimumab, which the FDA approved for advanced melanoma in 2011, activates the immune system, prompting T cells to start attacking the tumor. Blocking PD-1 further activates T cells in a different manner, allowing them to continue the attack.

"Previous studies had shown that ipilimumab alone could prolong overall survival in advanced melanoma patie
'/>"/>

Contact: Caitlin Hool
hoolc@mskcc.org
646-227-3956
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Melanoma Patients Receive Promising News Regarding Cancer Immunotherapy Combination Treatment
2. Underactive Thyroid and Heart Failure a Bad Combination: Study
3. Learn How to Incorporate Ayruveda into Yoga Practices, Discover Dosha Combinations, and How to Live in Balance this Saturday, May 18th at The YogaSoul Center
4. Added benefit of saxagliptin/metformin combination is not proven
5. New drug combination therapy developed to treat leukemia
6. Some patients with incurable tumors and BRCA mutations respond to new 2-drug combination
7. Different drug combinations work best for prevention versus treatment of colorectal tumors
8. Combination therapy provides similar clinical benefit as single drug treatment in MS
9. Comparing combination therapies for advanced head and neck cancer shows no improvement
10. New drug combination could prevent head and neck cancer in high-risk patients
11. Mayo Clinic: 2-drug combination may slow deadly thyroid cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 Doctors Scott Sullivan ... Restorative Breast Surgery (CRBS) and the St. ... pleased to announce that board certified Surgical Oncologist Dr. ... of surgeons. Ordoyne joins fellow breast surgical oncologist Alan ... including Frank DellaCroce, M.D., FACS; Scott Sullivan, M.D., FACS; ...
(Date:3/26/2015)... NJ (PRWEB) March 26, 2015 ... statistical consulting firm, announced the release of BathroomMap® ... experts to increase access to public restrooms for travelers, ... in bathroom apps, BathroomMap does not facilitate a paid, ... algorithm to identify and rate local establishments that have ...
(Date:3/26/2015)... 2015 U.S. medical real estate ... 2014, according to an exclusive new report now ... real estate (HRE) data firm also announced that ... new Gold-Level Partners: Harrison Street Real Estate Capital ... transactions still going strong, yields compressed, prices per ...
(Date:3/26/2015)... Philadelphia, PA (PRWEB) March 26, 2015 ... to identifying brain aneurysms and preventing often fatal ... non-profit organization dedicated to raising awareness of brain ... , The issue has captured national attention with ... Colagrossi , 49, who died last Friday after ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... the Patients’ Access to Treatments Act (PATA) that ... week by Reps. David B. McKinley (R-WV) and ... limit cost-sharing requirements for medications placed in a ... by reducing patients’ out-of-pocket expenses. , This legislation ...
Breaking Medicine News(10 mins):Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 2Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 4Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 2Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 3Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2
... Nov. 24 The holiday season can be a time ... many people, especially those recovering from an eating disorder, it,s ... anxiety about an uncertain future. Family gatherings with a loved ... and sometimes awkward. , "In my practice, I ...
... , SAN FRANCISCO, Nov. 24 ... and services provider, announced today that it has licensed ... of Michigan for integration into Quantros, suite of safety ... software within the SRM product family will enable automated ...
... N.Y., Nov. 24 IPRO has achieved its ... standard focused on fulfilling customer requirements, enhancing customer ... to ISO 9001:2008 by SGS International Certification Services ... a rigorous external audit encompassing operations at its ...
... needed when taking sedatives, antidepressants, benzodiazepines, review finds ... who take antidepressants, sedatives and other psychotropic medications ... new review shows. , Canadian researchers analyzed 22 ... participants older than 60. The studies evaluated nine ...
... Nov. 24 Governor Edward G. Rendell today announced ... vaccinated during the weekend at public health clinics held ... , "With the federal government unable to provide ... vaccine, distribution has been challenging," said Governor Rendell. "Overall, ...
... , , PITTSBURGH, Nov. 24 While ... celebrate, this time of the year can be difficult for ... death, every day is difficult for children and families. The ... grieving. , The Highmark Caring Place, A Center for Grieving ...
Cached Medicine News:Health News:When Holiday Meals Aren't a Gift 2Health News:When Holiday Meals Aren't a Gift 3Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 3Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2
(Date:3/26/2015)... SANTA CLARA , Kalifornien, 26. März ... neue Veranstaltung Cellworld 2015, die sich speziell ... Bioprozesstechnologien richtet, an. Die zweitägige ... bis 22. September 2015 im Hyatt Regency ... statt. In diesem Forum werden führende ...
(Date:3/26/2015)... de 2015 A Finesse Solutions anunciou a ... para os inovadores, visionários e executivos seniores em bioprocessamento. ... convite, será realizada no Hyatt Regency em ... de setembro de 2015. Será um fórum de líderes ... fabricação de produtos biofarmacêuticos de uso único e ouvir ...
(Date:3/26/2015)... , March 26, 2015 Finesse Solutions ... designed for innovators, visionaries and senior executives in bio-processing. ... will be held at the Hyatt Regency in ... 2015.  It will be a forum for life science ... and to hear about both disruptive technologies and best ...
Breaking Medicine Technology:Finesse Solutions kündigt Cellworld 2015 an 2Finesse Solutions anuncia Cellworld 2015 2Finesse Solutions Announces Cellworld 2015 2
... 2 60-ms bursts of 50 Hz separated by .75 ... Tetanus: 50 Hz (50 pulses/s) or 100 Hz (100 ... Output Current: Adjustable from 0-70 mA , Stimulus ... Battery LED (green) indicates that the units on; it ...
Anesthesia Associates Nerve Stimulator Model AA 1050...
... newest peripheral nerve stimulator from B. Braun Medical. ... providing advanced digital technology. , ,Your ability ... allows the localization of practically all mixed nerves ... ,An additional optional component for the HNS11 is ...
... original MS-III design the new ... keypad and battery ... MS-IV peripheral nerve stimulator can ... in operating room, post anesthesia ...
Medicine Products: